Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Ortega-Eslava, A. (Ana) | - |
| dc.creator | Fraga-Fuentes, M.D. (M.D.) | - |
| dc.creator | Puigventos, F. (Francesc) | - |
| dc.creator | Santos-Ramos, B. (B.) | - |
| dc.creator | Clopes-Estela, A. (A.) | - |
| dc.creator | Vilanova-Bolto, M. (M.) | - |
| dc.date.accessioned | 2012-07-30T11:22:45Z | - |
| dc.date.available | 2012-07-30T11:22:45Z | - |
| dc.date.issued | 2012 | - |
| dc.identifier.citation | Ortega Eslava A, Puigventos Latorre F, Santos-Ramos B, Calderon Hernanz B, Vilanova Bolto M, en representacion del Grupo de Evaluacion de Novedades, Estandarizacion e Investigacion en Seleccion de Medicamentos (GENESIS) de la Sociedad Española de Farmacia Hospitalaria (SEFH). Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH. Farm Hosp 2011 May-Jun;35(3):140-147 | es_ES |
| dc.identifier.issn | 1130-6343 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/22957 | - |
| dc.description.abstract | An active comparator was present in 95% of the 337 analysed reports; 50% included a direct comparative study vs comparator. In 114 reports (34%), an IC was used; 69% of the ICs were made by the report author. Most ICs were narrative and none were adjusted. An IC could have been made in an additional 16% of the cases and possibly in 24% more. Conclusions: Most evaluated drugs have an active comparator but studies comparing them directly are not as common. ICs could be included in more reports along with quality control criteria. © 2011 SEFH. Published | es_ES |
| dc.language.iso | spa | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.subject | Indirect comparisons | es_ES |
| dc.subject | Decision-making | es_ES |
| dc.subject | Drug evaluation | es_ES |
| dc.title | Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH | es_ES |
| dc.title.alternative | Indirect comparisons in drug assessment reports on the GENESIS group (SEFH) webpage | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.type.driver | info:eu-repo/semantics/article | es_ES |
| dc.identifier.doi | http://dx.doi.org/10.1016/j.farma.2011.11.005 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
